{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:55:44Z","timestamp":1768694144291,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003399","name":"science and technology commission of shanghai municipality","doi-asserted-by":"publisher","award":["19DZ2201000"],"award-info":[{"award-number":["19DZ2201000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11033-021-07026-0","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:03:39Z","timestamp":1641427419000},"page":"2085-2095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Scutellarein protects against cardiac hypertrophy via suppressing TRAF2\/NF-\u03baB signaling pathway"],"prefix":"10.1007","volume":"49","author":[{"given":"Xiujuan","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingshi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-8406","authenticated-orcid":false,"given":"Jue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"7026_CR1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1089\/ars.2007.1474","volume":"9","author":"S Gupta","year":"2007","unstructured":"Gupta S, Das B, Sen S (2007) Cardiac hypertrophy: mechanisms and therapeutic opportunities. Antioxid Redox Signal 9:623\u2013652. https:\/\/doi.org\/10.1089\/ars.2007.1474","journal-title":"Antioxid Redox Signal"},{"key":"7026_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1291\/hypres.22.1","volume":"22","author":"RB Devereux","year":"1999","unstructured":"Devereux RB, Roman MJ (1999) Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 22:1\u20139. https:\/\/doi.org\/10.1291\/hypres.22.1","journal-title":"Hypertens Res"},{"key":"7026_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1124\/jpet.104.065185","volume":"310","author":"Y Xia","year":"2004","unstructured":"Xia Y, Karmazyn M (2004) Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulation. J Pharmacol Exp Ther 310:43\u201351. https:\/\/doi.org\/10.1124\/jpet.104.065185","journal-title":"J Pharmacol Exp Ther"},{"key":"7026_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45\u201379. https:\/\/doi.org\/10.1146\/annurev.physiol.65.092101.142243","journal-title":"Annu Rev Physiol"},{"key":"7026_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/FJC.0000000000000126","volume":"64","author":"E Bisping","year":"2014","unstructured":"Bisping E, Wakula P, Poteser M, Heinzel FR (2014) Targeting cardiac hypertrophy: toward a causal heart failure therapy. J Cardiovasc Pharmacol 64:293\u2013305. https:\/\/doi.org\/10.1097\/FJC.0000000000000126","journal-title":"J Cardiovasc Pharmacol"},{"key":"7026_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR (2015) Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol 89:1401\u20131438. https:\/\/doi.org\/10.1007\/s00204-015-1477-x","journal-title":"Arch Toxicol"},{"key":"7026_CR7","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1128\/MCB.21.12.3986-3994.2001","volume":"21","author":"A Devin","year":"2001","unstructured":"Devin A, Lin Y, Yamaoka S, Li Z, Karin M, Liu Z (2001) The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol Cell Biol 21:3986\u20133994. https:\/\/doi.org\/10.1128\/MCB.21.12.3986-3994.2001","journal-title":"Mol Cell Biol"},{"key":"7026_CR8","doi-asserted-by":"publisher","first-page":"L622","DOI":"10.1152\/ajplung.00477.2005","volume":"290","author":"SF Liu","year":"2006","unstructured":"Liu SF, Malik AB (2006) NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290:L622\u2013L645. https:\/\/doi.org\/10.1152\/ajplung.00477.2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7026_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/heartjnl-2011-300960","volume":"98","author":"J Kuusisto","year":"2012","unstructured":"Kuusisto J, Karja V, Sipola P, Kholova I, Peuhkurinen K, Jaaskelainen P, Naukkarinen A, Yla-Herttuala S, Punnonen K, Laakso M (2012) Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart 98:1007\u20131013. https:\/\/doi.org\/10.1136\/heartjnl-2011-300960","journal-title":"Heart"},{"key":"7026_CR10","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066\u20131071. https:\/\/doi.org\/10.1056\/NEJM199704103361506","journal-title":"N Engl J Med"},{"key":"7026_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0092-8674(00)81318-5","volume":"87","author":"PA Baeuerle","year":"1996","unstructured":"Baeuerle PA, Baltimore D (1996) NF-kappa B: ten years after. Cell 87:13\u201320. https:\/\/doi.org\/10.1016\/s0092-8674(00)81318-5","journal-title":"Cell"},{"key":"7026_CR12","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181043","author":"Z Wang","year":"2018","unstructured":"Wang Z, Gao L, Xiao L, Kong L, Shi H, Tian X, Zhao L (2018) Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-kappaB signaling pathway. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20181043","journal-title":"Biosci Rep"},{"key":"7026_CR13","doi-asserted-by":"publisher","first-page":"11617","DOI":"10.1074\/jbc.M109.094961","volume":"285","author":"SK Manna","year":"2010","unstructured":"Manna SK, Babajan B, Raghavendra PB, Raviprakash N, Sureshkumar C (2010) Inhibiting TRAF2-mediated activation of NF-kappaB facilitates induction of AP-1. J Biol Chem 285:11617\u201311627. https:\/\/doi.org\/10.1074\/jbc.M109.094961","journal-title":"J Biol Chem"},{"key":"7026_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jneuroim.2017.01.015","volume":"305","author":"D Su","year":"2017","unstructured":"Su D, Cheng Y, Li S, Dai D, Zhang W, Lv M (2017) Sphk1 mediates neuroinflammation and neuronal injury via TRAF2\/NF-kappaB pathways in activated microglia in cerebral ischemia reperfusion. J Neuroimmunol 305:35\u201341. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.015","journal-title":"J Neuroimmunol"},{"key":"7026_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1745-7254.2008.00797.x","volume":"29","author":"R Gao","year":"2008","unstructured":"Gao R, Zhu BH, Tang SB, Wang JF, Ren J (2008) Scutellarein inhibits hypoxia- and moderately-high glucose-induced proliferation and VEGF expression in human retinal endothelial cells. Acta Pharmacol Sin 29:707\u2013712. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00797.x","journal-title":"Acta Pharmacol Sin"},{"key":"7026_CR16","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1016\/j.bmc.2012.10.015","volume":"20","author":"NG Li","year":"2012","unstructured":"Li NG, Song SL, Shen MZ, Tang YP, Shi ZH, Tang H, Shi QP, Fu YF, Duan JA (2012) Mannich bases of scutellarein as thrombin-inhibitors: design, synthesis, biological activity and solubility. Bioorg Med Chem 20:6919\u20136923. https:\/\/doi.org\/10.1016\/j.bmc.2012.10.015","journal-title":"Bioorg Med Chem"},{"key":"7026_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020263","author":"H Sang Eun","year":"2019","unstructured":"Sang Eun H, Seong Min K, Ho Jeong L, Vetrivel P, Venkatarame Gowda Saralamma V, Jeong Doo H, Eun Hee K, Sang Joon L, Sup K (2019) Scutellarein induces fas-mediated extrinsic apoptosis and G2\/M cell cycle arrest in Hep3B hepatocellular carcinoma cells. Nutrients. https:\/\/doi.org\/10.3390\/nu11020263","journal-title":"Nutrients"},{"key":"7026_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pbb.2014.01.003","volume":"118","author":"H Tang","year":"2014","unstructured":"Tang H, Tang Y, Li N, Shi Q, Guo J, Shang E, Duan JA (2014) Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats. Pharmacol Biochem Behav 118:51\u201359. https:\/\/doi.org\/10.1016\/j.pbb.2014.01.003","journal-title":"Pharmacol Biochem Behav"},{"key":"7026_CR19","first-page":"375","volume":"115","author":"J Zhou","year":"2002","unstructured":"Zhou J, Lei H, Chen Y, Li F, Ma C (2002) Ventricular remodeling by Scutellarein treatment in spontaneously hypertensive rats. Chin Med J (Engl) 115:375\u2013377","journal-title":"Chin Med J (Engl)"},{"key":"7026_CR20","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561\u20131566. https:\/\/doi.org\/10.1056\/NEJM199005313222203","journal-title":"N Engl J Med"},{"key":"7026_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.pharma.2010.11.004","volume":"69","author":"JC Stoclet","year":"2011","unstructured":"Stoclet JC, Schini-Kerth V (2011) Dietary flavonoids and human health. Ann Pharm Fr 69:78\u201390. https:\/\/doi.org\/10.1016\/j.pharma.2010.11.004","journal-title":"Ann Pharm Fr"},{"key":"7026_CR22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/jcb.22495","volume":"109","author":"L Yan","year":"2010","unstructured":"Yan L, Huang H, Tang QZ, Zhu LH, Wang L, Liu C, Bian ZY, Li H (2010) Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling. J Cell Biochem 109:1158\u20131171. https:\/\/doi.org\/10.1002\/jcb.22495","journal-title":"J Cell Biochem"},{"key":"7026_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/aps.2011.11","volume":"32","author":"JF Xing","year":"2011","unstructured":"Xing JF, You HS, Dong YL, Lu J, Chen SY, Zhu HF, Dong Q, Wang MY, Dong WH (2011) Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces. Acta Pharmacol Sin 32:655\u2013663. https:\/\/doi.org\/10.1038\/aps.2011.11","journal-title":"Acta Pharmacol Sin"},{"key":"7026_CR24","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/ptr.5127","volume":"28","author":"HS You","year":"2014","unstructured":"You HS, Xing JF, Lu J, Dong WH, Liu JT, Dong YL (2014) Influence of the gastrointestinal microflora and efflux transporters on the absorption of scutellarin and scutellarein. Phytother Res 28:1295\u20131300. https:\/\/doi.org\/10.1002\/ptr.5127","journal-title":"Phytother Res"},{"key":"7026_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10337-017-3260-z","volume":"80","author":"MQ Feng","year":"2017","unstructured":"Feng MQ, Song YH, Wu JX, Chen X, Bai XH, Zhang YQ (2017) Study on antitumour activity of scutellarin and its metabolite scutellarein by combining activity screening, target tissue distribution and pharmacokinetics. Chromatographia 80:427\u2013435. https:\/\/doi.org\/10.1007\/s10337-017-3260-z","journal-title":"Chromatographia"},{"key":"7026_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0014-5793(93)81291-7","volume":"317","author":"MA Bogoyevitch","year":"1993","unstructured":"Bogoyevitch MA, Glennon PE, Sugden PH (1993) Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett 317:271\u2013275. https:\/\/doi.org\/10.1016\/0014-5793(93)81291-7","journal-title":"FEBS Lett"},{"key":"7026_CR27","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.1074\/jbc.273.13.7725","volume":"273","author":"M Hoshijima","year":"1998","unstructured":"Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH (1998) The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem 273:7725\u20137730. https:\/\/doi.org\/10.1074\/jbc.273.13.7725","journal-title":"J Biol Chem"},{"key":"7026_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s0735-1097(01)01377-8","volume":"38","author":"G Valen","year":"2001","unstructured":"Valen G, Yan ZQ, Hansson GK (2001) Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307\u2013314. https:\/\/doi.org\/10.1016\/s0735-1097(01)01377-8","journal-title":"J Am Coll Cardiol"},{"key":"7026_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13075-017-1296-y","volume":"19","author":"T Saito","year":"2017","unstructured":"Saito T, Tanaka S (2017) Molecular mechanisms underlying osteoarthritis development: Notch and NF-kappaB. Arthritis Res Ther 19:94. https:\/\/doi.org\/10.1186\/s13075-017-1296-y","journal-title":"Arthritis Res Ther"},{"key":"7026_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/41493","volume":"388","author":"JA DiDonato","year":"1997","unstructured":"DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548\u2013554. https:\/\/doi.org\/10.1038\/41493","journal-title":"Nature"},{"key":"7026_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin Jr","year":"1996","unstructured":"Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649\u2013683. https:\/\/doi.org\/10.1146\/annurev.immunol.14.1.649","journal-title":"Annu Rev Immunol"},{"key":"7026_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00041433-199810000-00002","volume":"9","author":"BL Thurberg","year":"1998","unstructured":"Thurberg BL, Collins T (1998) The nuclear factor-kappa B\/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 9:387\u2013396. https:\/\/doi.org\/10.1097\/00041433-199810000-00002","journal-title":"Curr Opin Lipidol"},{"key":"7026_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10592","author":"N Etemadi","year":"2015","unstructured":"Etemadi N, Chopin M, Anderton H, Tanzer MC, Rickard JA, Abeysekera W, Hall C, Spall SK, Wang B, Xiong Y, Hla T, Pitson SM, Bonder CS, Wong WW, Ernst M, Smyth GK, Vaux DL, Nutt SL, Nachbur U, Silke J (2015) TRAF2 regulates TNF and NF-kappaB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1. Elife. https:\/\/doi.org\/10.7554\/eLife.10592","journal-title":"Elife"},{"key":"7026_CR34","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1093\/emboj\/18.23.6694","volume":"18","author":"JL Pomerantz","year":"1999","unstructured":"Pomerantz JL, Baltimore D (1999) NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18:6694\u20136704. https:\/\/doi.org\/10.1093\/emboj\/18.23.6694","journal-title":"EMBO J"},{"key":"7026_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.21037\/tcr.2017.04.01","volume":"6","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto S, Iwakuma T (2017) RIPK1-TRAF2 interplay on the TNF\/NF-kappaB signaling, cell death, and cancer development in the liver. Transl Cancer Res 6:94\u2013109. https:\/\/doi.org\/10.21037\/tcr.2017.04.01","journal-title":"Transl Cancer Res"},{"key":"7026_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/s1074-7613(00)80391-x","volume":"7","author":"WC Yeh","year":"1997","unstructured":"Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW (1997) Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715\u2013725. https:\/\/doi.org\/10.1016\/s1074-7613(00)80391-x","journal-title":"Immunity"},{"key":"7026_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.gene.2013.12.052","volume":"536","author":"Y Huang","year":"2014","unstructured":"Huang Y, Wu D, Zhang X, Jiang M, Hu C, Lin J, Tang J, Wu L (2014) Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT\/GSK3beta signaling. Gene 536:225\u2013231. https:\/\/doi.org\/10.1016\/j.gene.2013.12.052","journal-title":"Gene"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-07026-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T07:27:25Z","timestamp":1645514845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-07026-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["7026"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-07026-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors agree to publish the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}